SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Nuvelo (Nasdaq: NUVO)
An SI Board Since August 1997
Posts SubjectMarks Bans Symbol
286 28 0 NUVO
Emcee:  CharlieS Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
286Nuvelo Reports Fourth Quarter and Year End 2003 Results, Accomplishments and 200SemiBull-2/9/2004
285Nuvelo Licenses rNAPc2, a Novel Anticoagulant, From Dendreon Wednesday February SemiBull-2/9/2004
284Former Goldman Sachs Executive Joins Nuvelo Board of Directors Wednesday FebruaSemiBull-2/9/2004
2834:56PM Nuvelo files $75 mln shelf registration (NUVO) 4.50 +0.10 finance.yahoo.SemiBull-1/26/2004
282Focusing on biotech: SunAmerica manager likes Genzyme, Pozen, Nuvelo "...OSemiBull-11/19/2003
281Nuvelo Announces Phase 1 Alfimeprase Results Presented at the AIM Symposium TueSemiBull-11/18/2003
280Phase 1 Alfimeprase Results to Be Presented at the AIM Symposium Thursday NovemSemiBull-11/13/2003
279Nuvelo to Present at the CIBC World Markets Fourteenth Annual Healthcare ConfereSemiBull-11/8/2003
278Mark Perry Joins Nuvelo Board of Directors Tuesday October 14, 9:30 am ET SUNNSemiBull-10/14/2003
277Nuvelo Completes Financing Tuesday October 7, 10:54 am ET Underwriter exerciseSemiBull-10/7/2003
276Nuvelo Raises $24.5 Million Thursday October 2, 9:01 am ET SUNNYVALE, Calif., SemiBull-10/2/2003
275That's a pretty spartan PR. The sell-off today indicates investors were lootuck-9/25/2003
274Nuvelo Reports Successful Completion of Interim Analysis in Phase II Trial With SemiBull-9/25/2003
273Nuvelo to Present at the UBS Warburg Global Life Sciences Conference Thursday SSemiBull-9/18/2003
272Nuvelo Assigns Patents to SEQUENOM Wednesday September 17, 9:30 am ET SUNNYVALSemiBull-9/17/2003
271Nuvelo Appoints Vice President of Regulatory Affairs and Quality Assurance TuesSemiBull-8/5/2003
270Nuvelo Announces Second Quarter 2003 Financial Results and Accomplishments ThurSemiBull-7/31/2003
269Nuvelo files $50 million mixed shelf with SEC Tuesday July 8, 3:38 pm ET WASHISemiBull-7/8/2003
268uvelo Added to Russell 3000(R) Index Monday June 30, 9:01 am ET SUNNYVALE, CalSemiBull-6/30/2003
267SemiBull I sold all 4 of my positions of NUVO a few weeks ago. Held most from bFindit-6/24/2003
266Nuvelo Initiates Phase II Clinical Trial in Acute Peripheral Arterial Occlusion SemiBull-6/24/2003
265Nuvelo Appoints Jan Johansson, MD, PhD, to Lead Clinical Affairs Monday June 9, SemiBull-6/11/2003
264>>SUNNYVALE, Calif., June 5 /PRNewswire-FirstCall/ -- Nuvelo, Inc. (Nasdaqtuck-6/5/2003
263Nuvelo Announces First Quarter 2003 Financial Results and Accomplishments ThursSemiBull-5/6/2003
262Nuvelo Announces Successful Results in Phase I Clinical Trial Thursday March 27SemiBull-3/27/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News